At ShangPharma Innovation, we understand scientific founders.
You’ve devoted years — maybe decades — to research that could lead to a therapeutic breakthrough that improves patients’ lives. The success or failure of this one idea could define your legacy.
Now you’re ready to pursue clinical development. But unless you’re a known commodity with a few wins under your belt, most healthcare venture capital firms won’t be interested. The lack of viable funding options for less established entrepreneurs is why so many promising early-stage ideas never get out of the lab.
ShangPharma is a healthcare investment firm with a different perspective than the VC firms. We specialize in identifying early-stage gems that can advance quickly with the right combination of funding, scientific expertise and operational support. Based on the specific requirements of each project, we assemble a small team drawn from our roster of executives-in-residence and strategic advisors/consultants.
Recognizing that you are the subject matter expert, we embrace a founder-centric vision in which entrepreneurs can remain actively involved in shaping their company’s success. Our mission is to collaborate with you to advance your technology from the lab to the clinic. Then, we can help you determine the best path to FDA approval — whether it’s pursuing a significant raise or selling the company to the right buyer.
ShangPharma has a track record of finding and de-risking brilliant, budding ideas with the potential to become transformative medicines and generate significant investment returns. To learn more, please contact us today.
